Effects of Interfractional Motion and Anatomic Changes on Proton Therapy Dose Distribution in Lung Cancer

Adaptive re-planning during proton therapy may be indicated in selected patients with non-small cell lung cancer. For most patients, however, CTV coverage is adequate if tumor motion is taken into consideration in the original simulation and planning processes.